Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KIMURA, H.
Right arrow Articles by MIYAZAKI, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KIMURA, H.
Right arrow Articles by MIYAZAKI, R.
J Am Soc Nephrol 11:885-893, 2000
© 2000 American Society of Nephrology


REGULAR ARTICLES

The C677T Methylenetetrahydrofolate Reductase Gene Mutation in Hemodialysis Patients

HIDEKI KIMURA*, FUMITAKE GEJYO{ddagger}, SATORU SUZUKI* and RYOICHI MIYAZAKI{dagger}

* Department of Clinical and Laboratory Medicine, Faculty of Medicine, Fukui Medical University, Fukui, Japan
{dagger} Fujita Memorial Hospital, Fukui, Japan
{ddagger} Department of Medicine (II), Niigata University School of Medicine, Niigata, Japan.

Correspondence to Dr. Hideki Kimura, Department of Clinical and Laboratory Medicine, Faculty of Medicine, Fukui Medical University, 23 Shimoaitsuki, Matsuoka, Fukui 910-1193, Japan. Phone: +81 0776 61 3111, extension 2412; Fax: +81 0776 61 8120; E-mail: hkimura{at}fmsrsa.fukui-med.ac.jp

Abstract. Hyperhomocysteinemia, which results from renal impairment, may promote arteriosclerosis and glomerulosclerosis. The combined effect of renal failure and a common mutation (C677T) in the methylenetetrahydrofolate reductase gene that leads to serum homocysteine elevations in dialysis patients was investigated. Genotypes were determined at this locus in 545 dialysis patients and 676 healthy subjects, and serum concentrations of total homocysteine and folate were measured in a subgroup of 464 patients. Multiple regression analysis showed that the TT genotype and low serum folate concentration were independent positive predictors of the serum total homocysteine concentration. The negative slope of a regression line relating homocysteine and folate concentrations was significantly steeper for patients with the TT genotype than for other genotypes. Patients with the TT genotype were significantly younger at the time of the study (54.8 ± 12.9 versus 59.6 ± 12.3 yr; P < 0.0001) and at initiation of dialysis (46.6 ± 16.2 versus 51.2 ± 15.9 yr; P < 0.02) than those with other genotypes. In patients who were older at the time of the study or at initiation of dialysis, the prevalence of the TT genotype was lower than in control subjects. In the middle quartiles (37.1 to 63.0 yr) for age at the start of dialysis, the prevalence of the TT genotype was lower in patients with a longer duration of dialysis. In this cross-sectional study, genotype and serum total homocysteine concentration were not independent risk factors for vascular disease in dialysis patients. These results indicate that the methylenetetrahydrofolate reductase mutation is a significant independent predictor for serum total homocysteine concentration.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
F. Aucella, M. Margaglione, E. Grandone, M. Vigilante, G. Gatta, M. Forcella, M. Ktena, A. De Min, G. Salatino, D. A. Procaccini, et al.
The C677T methylenetetrahydrofolate reductase gene mutation does not influence cardiovascular risk in the dialysis population: results of a multicentre prospective study
Nephrol. Dial. Transplant., February 1, 2005; 20(2): 382 - 386.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. M. Wrone, J. M. Hornberger, J. L. Zehnder, L. M. McCann, N. S. Coplon, and S. P. Fortmann
Randomized Trial of Folic Acid for Prevention of Cardiovascular Events in End-Stage Renal Disease
J. Am. Soc. Nephrol., February 1, 2004; 15(2): 420 - 426.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. Billion, B. Tribout, E. Cadet, C. Queinnec, J. Rochette, P. Wheatley, and P. Bataille
Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12
Nephrol. Dial. Transplant., March 1, 2002; 17(3): 455 - 461.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. N. FRIEDMAN, A. G. BOSTOM, J. SELHUB, A. S. LEVEY, and I. H. ROSENBERG
The Kidney and Homocysteine Metabolism
J. Am. Soc. Nephrol., October 1, 2001; 12(10): 2181 - 2189.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP